Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncofid-P-B in Non-muscle Invasive Bladder Cancer
NCT04661826Phase 2Completed
- Sponsor
- Fidia Farmaceutici
- Start
- May 2010
- Primary completion
- Jul 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of Oncofid-P-B in bladder cancer, sponsored by Fidia Farmaceutici. Primary endpoint: Complete Response at control visit (V8). Started May 2010; status: completed.
02
Drugs
Oncofid-P-B
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04661826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04661826.